{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:55:53Z","timestamp":1783187753483,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cjca.2015.11.017","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T12:49:11Z","timestamp":1448542151000},"page":"938-940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Amlodipine Therapy for Iron-Overload Cardiomyopathy: The Enduring Value of Translational Research"],"prefix":"10.1016","volume":"32","author":[{"given":"Gavin Y.","family":"Oudit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Backx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2015.11.017_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nm0496-394","article-title":"Hemochromatosis: the genetic disorder of the twenty-first century","volume":"2","author":"Barton","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib2","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1004967","article-title":"Iron overload in human disease","volume":"366","author":"Fleming","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2015.11.017_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.11.017_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nm0896-847","article-title":"Thalassemia\u2014a global public health problem","volume":"2","author":"Weatherall","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCEP.110.960401","article-title":"Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation","volume":"4","author":"Rose","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2015.11.017_bib9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib10","first-page":"1009","article-title":"Effects of iron overload on cardiac calcium regulation: translational insights into mechanisms and management of a global epidemic","volume":"32","author":"Khamseekaew","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.11.017_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0609.2010.01549.x","article-title":"T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice","volume":"86","author":"Kumfu","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cjca.2015.11.017_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1527-3466.2002.tb00084.x","article-title":"Efonidipine hydrochloride: a dual blocker of L-\u00a0and T-type ca(2+) channels","volume":"20","author":"Tanaka","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.cjca.2015.11.017_bib13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2015.11.017_bib14","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/01.CIR.0000124229.40424.80","article-title":"Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model","volume":"109","author":"Oudit","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.11.017_bib15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.CIR.88.3.1127","article-title":"Left ventricular diastolic Doppler characteristics in beta-thalassemia major","volume":"88","author":"Kremastinos","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.11.017_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00877096","article-title":"Iron overload cardiomyopathies: new insights into an old disease","volume":"8","author":"Liu","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cjca.2015.11.017_bib17","series-title":"Hemochromatosis: Genetics, Pathophysiology, Diagnosis, and Treatment","first-page":"297","article-title":"Cardiac abnormalities in hemochromatosis","author":"Muhlestein","year":"2000"},{"key":"10.1016\/j.cjca.2015.11.017_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM200008243430804","article-title":"Genetic and clinical features of hemoglobin H disease in Chinese patients","volume":"343","author":"Chen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib19","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1038\/srep18132","article-title":"Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy","volume":"5","author":"Das","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2015.11.017_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2010.11.002","article-title":"Interdependence of cardiac iron and calcium in a murine model of iron overload","volume":"157","author":"Otto-Duessel","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.cjca.2015.11.017_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1536\/ihj.50.829","article-title":"A\u00a0case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction","volume":"50","author":"Sugishita","year":"2009","journal-title":"Int Heart J"},{"key":"10.1016\/j.cjca.2015.11.017_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.amjmed.2013.05.002","article-title":"Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial","volume":"126","author":"Fernandes","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy","volume":"84","author":"Oudit","year":"2006","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib24","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.11.017_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.0000046488.52939.BF","article-title":"Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin on Recovery of Coronary Endothelial Function)","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.11.017_bib26","doi-asserted-by":"crossref","first-page":"16L","DOI":"10.1016\/S0002-9149(99)00360-4","article-title":"Antioxidant properties of calcium antagonists related to membrane biophysical interactions","volume":"84","author":"Mason","year":"1999","journal-title":"Am J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15016207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15016207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:45:57Z","timestamp":1774860357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X15016207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0828282X15016207"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2015.11.017","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlodipine Therapy for Iron-Overload Cardiomyopathy: The Enduring Value of Translational Research","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2015.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}